However, when treated with Gal, both TRAMP-C1 (shHic1) and TRAMP-C1 (shCtrl) cell-derived tumor tissues exhibited significant tumor growth inhibition and lower tumor weight, indicating that targeting TGF-β signaling was able to prevent tumor growth (Fig. 6c–e). This evidence concerns the gene TGFB1 and neoplasm.